HomeNewsBusinessStocksBuy GlaxoSmithKline Con; target of Rs 2755: Anand Rathi Sec

Buy GlaxoSmithKline Con; target of Rs 2755: Anand Rathi Sec

Anand Rathi Securities is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target of Rs 2755 in its February 3, 2011 research report.

February 07, 2011 / 14:11 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Anand Rathi Securities is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target of Rs 2755 in its February 3, 2011 research report.

first published: Feb 7, 2011 01:54 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347